Literature DB >> 19914598

The role of acetaldehyde in human psychomotor function: a double-blind placebo-controlled crossover study.

Sung-Wan Kim1, Kyung-Yeol Bae, Hee-Young Shin, Jae-Min Kim, Il-Seon Shin, Tak Youn, Jin Kim, Jong-Keun Kim, Jin-Sang Yoon.   

Abstract

BACKGROUND: Acetaldehyde, the first product of ethanol metabolization, is a biologically active compound, but the behavioral properties of acetaldehyde in humans are largely undefined. We investigated the acute effects of both alcohol and acetaldehyde on psychomotor functions related to automobile driving skills.
METHODS: Twenty-four men were selected through genotyping; one-half had the ALDH2*1/*1 (active form) genotype and one-half had the ALDH2*1/*2 (inactive form) genotype. In a double-blind placebo-controlled crossover design, each subject was administered one of the following doses of alcohol: .25 g/kg, .5 g/kg, or .75 g/kg or a placebo in four trials that took place at 1-week intervals. Blood ethanol concentration (BEC) and blood acetaldehyde concentration (BAAC) were measured nine times, and psychomotor function tests (critical flicker fusion threshold, choice reaction time, compensatory tracking task, and digit symbol substitution test) were assessed seven times in total over 4 hours after study drug ingestion.
RESULTS: After the consumption of alcohol, BEC was comparable in the two subject groups, whereas BAAC was significantly higher in subjects with ALDH2 *1/*2 than in those with ALDH2 *1/*1. The psychomotor performance of subjects with ALDH2*1/*2 was significantly poorer than that of subjects with ALDH2*1/*1. Significant correlations between psychomotor performance and both BEC and BAAC were observed. However, in the linear regression analysis, BAAC significantly predicted poorer psychomotor performance, whereas BEC was not associated with any measure of psychomotor function.
CONCLUSIONS: Acetaldehyde might be more important than alcohol in determining the effects on human psychomotor function and skills. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19914598     DOI: 10.1016/j.biopsych.2009.10.005

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  7 in total

1.  Locally-generated Acetaldehyde Contributes to the Effects of Ethanol on Neurosteroids and LTP in the Hippocampus.

Authors:  Kazuhiro Tokuda; Yukitoshi Izumi; Charles F Zorumski
Journal:  Neurol Clin Neurosci       Date:  2013-07

2.  Kudzu extract treatment does not increase the intoxicating effects of acute alcohol in human volunteers.

Authors:  David M Penetar; Robert R Maclean; Jane F McNeil; Scott E Lukas
Journal:  Alcohol Clin Exp Res       Date:  2011-01-18       Impact factor: 3.455

3.  Locally-generated acetaldehyde is involved in ethanol-mediated LTP inhibition in the hippocampus.

Authors:  Kazuhiro Tokuda; Yukitoshi Izumi; Charles F Zorumski
Journal:  Neurosci Lett       Date:  2013-01-24       Impact factor: 3.046

Review 4.  Glu504Lys Single Nucleotide Polymorphism of Aldehyde Dehydrogenase 2 Gene and the Risk of Human Diseases.

Authors:  Yan Zhao; Chuancai Wang
Journal:  Biomed Res Int       Date:  2015-09-27       Impact factor: 3.411

Review 5.  Alcohol Consumption, Aldehyde Dehydrogenase 2 Gene Polymorphisms, and Cardiovascular Health in Korea.

Authors:  Min Jeong Shin; Yoonsu Cho; George Davey Smith
Journal:  Yonsei Med J       Date:  2017-07       Impact factor: 2.759

6.  Essential medicines containing ethanol elevate blood acetaldehyde concentrations in neonates.

Authors:  H C Pandya; H Mulla; M Hubbard; R L Cordell; P S Monks; S Yakkundi; J C McElnay; A J Nunn; M A Turner
Journal:  Eur J Pediatr       Date:  2016-03-21       Impact factor: 3.183

7.  ALDH2 Gene: Its Effects on the Neuropsychological Functions in Patients with Opioid Use Disorder Undergoing Methadone Maintenance Treatment.

Authors:  Po-Wei Lee; Tzu-Yun Wang; Yun-Hsuan Chang; Sheng-Yu Lee; Shiou-Lan Chen; Ze-Cheng Wang; Po See Chen; Chun-Hsien Chu; San-Yuan Huang; Nian-Sheng Tzeng; I Hui Lee; Kao Chin Chen; Yen Kuang Yang; Jau-Shyong Hong; Ru-Band Lu
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-02-29       Impact factor: 2.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.